Andrew D. Goldberg Tarsus Pharmaceuticals, Inc. (TARS) insider trading activity
Andrew D. Goldberg is Director of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 13,350 shares of TARS, which is worth approximately $690,729. The most recent transaction as insider was on Mar 07, 2025, when has been sold 7,000 shares (Common Stock) at a price of $12.89 per share, resulting in proceeds of $90,230. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
13.4K
110.24%
3M change
345.0%
12M change
Total Value Held
$690,729
Andrew D. Goldberg Transaction History
ADG
Andrew D. Goldberg
Director
Irvine, CA